Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Mar 28, 2007 at 3:01 AM EDT

Tuesday’s Top Biotech & Medical Stocks

From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotechnology NUVELO INC NEW [NUVO] +24.92% NEOSE TECH INC [NTEC] +20.67% CARDIOVASCULAR BIOTH…

Douglas A. McIntyre | Mar 28, 2007 at 2:58 AM EDT

eXegenics: Dr.Frost Continues His Hot Hand

by H.S. AyoubBioHealth Investor.com Back in February, I recommended investing in Continucare (CNU) after doctor Phillip Frost, founder of Ivax…

Douglas A. McIntyre | Mar 28, 2007 at 1:29 AM EDT

Dendreon’s Last Day (Ahead of the FDA)

Dendreon (DNDN-NASDAQ) has only 1 trading day left before its FDA panel meeting over the potential backing of its Provenge…

Douglas A. McIntyre | Mar 27, 2007 at 3:10 AM EDT

Patient Investors: Take a Look at Amgen

From Chad Brand at Peridot Capitalist As a value investor, it is often easier to find undiscovered or unloved stocks…

Douglas A. McIntyre | Mar 27, 2007 at 3:08 AM EDT

Weekly Top Biotech and Medical Business Articles

From BioHealth Investor by H.S. AyoubBioHealth Investor.com The following articles were the most popular at BioHealth Investor for the week…

Douglas A. McIntyre | Mar 26, 2007 at 6:04 PM EDT

CombinatoRx, Maybe Not As Bad As It Looked

CombinatoRx (CRXX) is still down in after-hours trading, but nowhere near the levels that it looked like the stock was…

Douglas A. McIntyre | Mar 26, 2007 at 3:30 PM EDT

Biotech Implosion: CombinatoRx (CRXX)

If having a difficult to say and spell name wasn’t bad enough, issuing poor study results will do it. CombinatoRx,…

Douglas A. McIntyre | Mar 26, 2007 at 2:09 PM EDT

Two Less Followed Stent-Related Companies At Risk

There are two companies that are not as frequently referred to in stent-land, and depending on how you interpret today’s…

Douglas A. McIntyre | Mar 26, 2007 at 8:26 AM EDT

Boston Scientific Bad Hair Day: Stent Applications Narrow

A new, very large test, shows that bare-metal stents barely work in patients with chronic chest pain who have their…

Douglas A. McIntyre | Mar 26, 2007 at 8:18 AM EDT

Pfizer Gets Bitten

Life does not get any easier for Pfizer (PFE). Forget generics. Now other drug firms are ganging up on them.…

Douglas A. McIntyre | Mar 26, 2007 at 4:00 AM EDT

A Make or Break Week for Dendreon (DNDN)

Dendreon(DNDN-NASDAQ) is going to be one of "THE TOP ISSUES" this week. The company will have and FDA review panel…

Douglas A. McIntyre | Mar 26, 2007 at 3:23 AM EDT

IBD Weekly Top Ranked Medical Stocks

The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s…

Douglas A. McIntyre | Mar 25, 2007 at 4:13 PM EDT

Additional Dendreon Data Ahead of its Provenge FDA Review

I have received comments on Dendreon (DNDN-NASDAQ) for this week that are both positive and negative on how well its…

Douglas A. McIntyre | Mar 23, 2007 at 9:10 AM EDT

Dendreon Interest Remains; Volume Already Beat Average Day

Dendreon (DNDN-NASDAQ) is still getting plenty of trader attention this morning. It is going to post significantly higher volume than…

Douglas A. McIntyre | Mar 23, 2007 at 5:59 AM EDT

Can Amgen Get the Gorilla Off Its Neck?

Shares of biotech giant Amgen (AMGN) fell another 4% last night after the company announced more negative news. The company…

1 … 375 376 377 378 379 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Tuesday’s Top Biotech & Medical Stocks

eXegenics: Dr.Frost Continues His Hot Hand

Dendreon’s Last Day (Ahead of the FDA)

Patient Investors: Take a Look at Amgen

Weekly Top Biotech and Medical Business Articles

CombinatoRx, Maybe Not As Bad As It Looked

Biotech Implosion: CombinatoRx (CRXX)

Two Less Followed Stent-Related Companies At Risk

Boston Scientific Bad Hair Day: Stent Applications Narrow

Pfizer Gets Bitten

A Make or Break Week for Dendreon (DNDN)

IBD Weekly Top Ranked Medical Stocks

Additional Dendreon Data Ahead of its Provenge FDA Review

Dendreon Interest Remains; Volume Already Beat Average Day

Can Amgen Get the Gorilla Off Its Neck?

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Health and Healthcare Articles

All Health and Healthcare Articles

Tuesday’s Top Biotech & Medical Stocks

eXegenics: Dr.Frost Continues His Hot Hand

Dendreon’s Last Day (Ahead of the FDA)

Patient Investors: Take a Look at Amgen

Weekly Top Biotech and Medical Business Articles

CombinatoRx, Maybe Not As Bad As It Looked

Biotech Implosion: CombinatoRx (CRXX)

Two Less Followed Stent-Related Companies At Risk

Boston Scientific Bad Hair Day: Stent Applications Narrow

Pfizer Gets Bitten

A Make or Break Week for Dendreon (DNDN)

IBD Weekly Top Ranked Medical Stocks

Additional Dendreon Data Ahead of its Provenge FDA Review

Dendreon Interest Remains; Volume Already Beat Average Day

Can Amgen Get the Gorilla Off Its Neck?

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do